Therefore, an enhanced response of Th2 cells, derived from CD4+ T cells in reaction to extracellular parasites or allergens (or other unknown factors) and leading to increased IL-5 secretion, is associated with a more favorable clinical status in ALS patients. This evidence concerns the gene IL5 and amyotrophic lateral sclerosis.